Tzyy-Jye Doong, Ph.D.

Affiliations: 
2002 Ohio State University, Columbus, Columbus, OH 
Area:
Plant Physiology
Google:
"Tzyy-Jye Doong"

Parents

Sign in to add mentor
James Metzger grad student 2002 Ohio State
 (Regulation of gibberellin metabolism by environmental factors in Arabidopsis thaliana.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chiang CL, Hu EY, Chang L, et al. (2022) Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity. Cell Reports. 40: 111115
Saygin C, Hu E, Zhang P, et al. (2021) Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq. Leukemia
Hu EY, Blachly JS, Saygin C, et al. (2020) LC-FACSeq is a method for detecting rare clones in leukemia. Jci Insight. 5
Lucas F, Larkin K, Gregory CT, et al. (2020) Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations. Blood
Woyach J, Huang Y, Rogers K, et al. (2019) Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations Blood. 134: 504-504
Hu E, Ozer HG, Lozanski A, et al. (2019) LC-Facseq: A Novel Method for Detecting Rare Resistant Clones in Leukemia Blood. 134: 3377-3377
Woyach JA, Ruppert AS, Guinn D, et al. (2017) BTK(C481S)-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016702282
Woyach JA, Guinn D, Ruppert AS, et al. (2016) the Development and Expansion of Resistant Subclones Precedes Relapse during Ibrutinib Therapy in Patients with CLL Blood. 128: 55-55
See more...